Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain.
SEMERGEN New Technologies Working Group, Madrid, Spain.
PLoS One. 2022 Dec 1;17(12):e0277899. doi: 10.1371/journal.pone.0277899. eCollection 2022.
This study attempts to provide a picture of the hesitancy to vaccination against COVID-19 in Spain during the 2021 spring-autumn vaccination campaign, both in the general population and in healthcare professionals.
The participants were recruited using social media such as Facebook and Twitter, in addition to the cooperation of health personnel contacted with the collaboration of medical scientific societies. A cross-sectional study was carried out that included the response of an online questionnaire. The data were collected from April 30 to September 26, 2021. To assess the different associations between variables to be measured, we fit Poisson regression models with robust variance.
Responses were obtained from 3,850 adults from the general population group and 502 health professionals. Of the overall sample, 48.6% of participants from the general population were vaccinated against COVID-19, whereas in the healthcare professionals, 94.8% were vaccinated. The prevalence of general population vaccination increased with age, and was higher in women than men. Most participants did not show a preference for any vaccine itself. However, the prevalence of people vaccinated with their preferred vaccine was higher for the ones vaccinated with Pfizer's vaccine. 6.5% of the general population reported being reticent to be vaccinated. People from younger age groups, people with lower educational levels and those who were not from a risk group showed greater reluctance to be vaccinated. No gender differences in reluctancy were found.
Health professionals were significantly less likely to refuse vaccination even though they had more doubts about the safety and efficacy of vaccines. On the other hand, younger people, those with a lower level of education and those who were not from a risk group were the most hesitant.
本研究试图描绘 2021 年春-秋季疫苗接种期间西班牙普通人群和医疗保健专业人员对接种 COVID-19 疫苗的犹豫情况。
使用 Facebook 和 Twitter 等社交媒体以及与医疗科学协会合作联系的卫生人员来招募参与者。开展了一项横断面研究,包括对在线问卷的回应。数据于 2021 年 4 月 30 日至 9 月 26 日收集。为了评估待测量变量之间的不同关联,我们拟合了具有稳健方差的泊松回归模型。
从普通人群组中获得了 3850 名成年人和 502 名卫生专业人员的回应。在整个样本中,48.6%的普通人群参与者接种了 COVID-19 疫苗,而在医疗保健专业人员中,94.8%接种了疫苗。普通人群的疫苗接种率随年龄增长而增加,女性高于男性。大多数参与者对任何疫苗本身都没有偏好。然而,接种首选疫苗的人的疫苗接种率更高,接种辉瑞疫苗的人更高。6.5%的普通人群表示对接种犹豫不决。年龄较小、受教育程度较低且不属于风险群体的人表现出更大的接种犹豫。未发现性别差异。
尽管医疗保健专业人员对接种疫苗的安全性和有效性存在更多疑虑,但他们拒绝接种疫苗的可能性显著降低。另一方面,年轻人、受教育程度较低且不属于风险群体的人最犹豫不决。